VEGF-E enhances endothelialization and inhibits thrombus formation on polymeric surfaces

Journal of Biomedical Materials Research - Part A

Volumn 93, Issue 1, 2010, Pages 77-85

  Knetsch, Menno L W ^a   Koole, Leo H ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Blood compatibility; Endothelialization; Heparin; Vascular endothelial growth factor; Vascular graft

Indexed keywords

ANTI-COAGULANT DRUGS; BIOFUNCTIONALIZATION; BLOOD COMPATIBILITY; CARDIOVASCULAR IMPLANTS; COLLAGEN I; CONTACTING SURFACES; ECONOMICAL STRATEGY; ENDOTHELIALIZATION; HAEMOSTASIS; PLATELET ADHESION; POLYMERIC COATINGS; POLYMERIC SURFACES; SMALL DIAMETER VASCULAR PROSTHESIS; SYNTHETIC SURFACES; THROMBIN GENERATION; THROMBUS FORMATION; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR GRAFTS;

ADHESION; ADSORPTION; BIOACTIVITY; BLOOD; BLOOD SUBSTITUTES; BLOOD VESSEL PROSTHESES; COAGULATION; COATINGS; COLLAGEN; ESCHERICHIA COLI; GRAFTING (CHEMICAL); GRAFTS; PEPTIDES; PLATELETS; POLYSACCHARIDES; PURIFICATION; SELF ASSEMBLY;

ENDOTHELIAL CELLS;

COLLAGEN TYPE 1; COPOLYMER; HEPARIN; VASCULOTROPIN E;

ARTICLE; BLOOD VESSEL PROSTHESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; POLYMERIZATION; PROTEIN PURIFICATION; THROMBOCYTE ADHESION; THROMBOGENESIS;

ADSORPTION; ANIMALS; CATTLE; CELL PROLIFERATION; COLLAGEN TYPE I; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIAL CELLS; HUMANS; PLATELET ADHESIVENESS; POLYMERS; SURFACE PROPERTIES; THROMBOSIS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTORS; VIRAL PROTEINS;

EID: 77649221676     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32538     Document Type: Article

References (47)

1. L'Heureux N, Dusserre N, Marini A, Garrido S, de la Fuente L, McAllister T. Technology insight: The evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat Clin Prac 2007;4:389-395.
2. Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM. Current status of prosthetic bypass grafts: A review. J Biomed Mater Res Part B: Appl Biomater 2005;74B:570-581.
3. Kakisis JD, Liapis CD, Breuer C Sumpio BE. Artificial blood vessels: The holy grail of peripheral vascular surgery. J Vasc Surg 2005;41:349-354.
4. Tiwari A, Salacinski H, Seifalian AM, Hamilton G. New prostheses for use in bypass grafts with special emphasis on polyurethanes. Cardiovasc Surg 2002;10:191-197.
5. Tiwari A, Salacinski HJ, Hamilton G, Seifalian AM. Tissue engineering of vascular bypass grafts: Role of endothelial cell extraction. Eur J Endovasc Surg 2001;21:193-201.
6. Bordenave L, Ferandez P, Rémy-Zolghardi M, Daculsi R, Midy D. In vitro endothelialized ePTFE prostheses: Clinical update 20 years after the first realization. Clin Hemorheol Microcirc 2005;33:227-234.
7. Becker BF, Heindl B, Kupatt C, Zahler S. Endothelial function and hemostasis. Z Kardiol 2000;89:160-167.
8. McGuigan AO, Sefton MV. The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials 2007;28:2547-2571.
9. Zubilewicz T, Wronski J, Bourriez A, Terlecki P, Guinault A, Muscatelli-Groux B, Michalak J, Méllière D, Becquemin JP, Allaire E. Injury in vascular surgery-the intimal hyperplastic response. Med Sci Monit 2001;7:316-324.
10. Seifalian AM, Tiwari A, Hamilton G, Salacinski HJ. Improving the clinical patency of prosthetic vascular and coronary grafts: The role of seeding and tissue engineering. Artif Organs 2002;26:307-320.
11. Pawlowski KJ, Rittgers SE, Schmidt SP, Bowlin GL. Endothelial cell seeding of polymeric vascular grafts. Front Biosci 2004;9:1412-1421.
12. Dixit P, Hern-Anderson D, Ranieri J, Schmidt CE. Vascular graft endothelialization: Comparative analysis of canine and human endothelial cell migration on natural biomaterials. J Biomed Mater Res 2001;56:545-555.
13. Greisler HP, Gosselin C, Ren D, Kang SS, Kim DU. Biointeractive polymers and tissue engineered blood vessels. Biomaterials 1996;17:329-336.
14. Chan BP, Liu W, Klitzman B, Reichert WM, Truskey GA. In vivo performance of dual ligand augmented endothelialized expanded polytetrfluoroethylene vascular grafts. J Biomed Mater Res Part B: Appl Biomater 2004;72B:52-63.
15. Pollara P, Alessandri G, Bonardelli S, Simioni A, Cabibbo E, Portolani N, Tiberio GAM, Giulini SM, Turano A. Complete in vitro prosthesis endothelialization induced by artifical extracellular matrix. J Invest Surg 1999;12:81-88.
16. Hoenig MR, Campbell GR, Rolfe BE, Campbell JH. Tissueengineered blood vessels. Alternative to autologous grafts? Arterioscler Thromb Vasc Biol 2005;25:1128-1134.
17. Walluscheck KP, Steinhoff G, Kelm S, Haverich A. Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic TGD-containing peptides. Eur J Vasc Endovasc Surg 1996;12:321-330.
18. Chung T, Lu Y, Wang S, Lin Y, Chu S. Growth of human endothelial cells on photochemically grafted Gly-Arg-Gly-Asp (GRGD) chitosans. Biomaterials 2002;23:4803-4809.
19. Fussell GW, Cooper SL. Endothelial cell adhesion on RGDcontaining methacrylate terpolymers. J Biomed Mater Res 2004;70A:265-273.
20. Larsen CC, Kligman F, Kottke-Marchant K, Marchant RE. The effect of RGD fluorosurfactant polymer modification of ePTFE on endothelial cell adhesion, growth, and function. Biomaterials 2006;27:4846-4855.
21. Kidane AG, Punshon G, Salacinski HJ, Ramesh B, Dooley A, Olbrich M, Heitz J, Hamilton G, Seifalian AM. Incorporation of a lauric acid-conjugated GRGDS peptide directly into the matrix of a poly(carbonate-urea)urethane polymer for use in cardiovascular bypass graft applications. J Biomed Mater Res 2006;79A:606-617.
22. Heemskerk JWM, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002;88:186-193.
23. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: Roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004;25:5681-5703.
24. Keuren JFW, Wielders SJH, Driessen A, Verhoeven M, Hendriks M, Lindhout T. Covalent-bound heparin makes collagen thromboresistant. Arterioscler Thromb Vasc Biol 2004;24:613-617.
25. Heemskerk JWM, Kuijpers MJE, Munnix ICA, Siljander PRM. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med 2005;15:86-92.
26. Swanson N, Hogrefe K, Javed Q, Malik N, Gershlick AH. Vascular endothelial growth factor (VEGF)-eluting stents: In vivo effects on thrombosis, endothelialization and intimal hyperplasia. J Invas Cardiol 2003;15:688-692.
27. Randone B, Cavallaro G, Polistena A, Cucina A, Coluccia P, graziano P, Cavallaro A. Dual role of VEGF in pretreated experimental ePTFE arterial grafts. J Surg Res 2005;127:70-79.
28. Doi K, Matsuda T. Enhanced vascularization in a microporous polyurethane graft impregnated with basic fibroblast growth factor and heparin. J Biomed Mater Res 1997;34:361-370.
29. Kang SS, Gosselin C, Ren D, Greisler HP. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered form fibrin glue suspensions. Surgery 1995;118:280-287.
30. Wissink MJB, Beernink R, Scharenborg NM, Poot AA, Engbers GHM, Beugeling T, van Aken WG, Feijen J. Endothelial cell seeding of (heparinized) collagen matrices: Effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors. J Control Release 2000;67:141-155.
31. Dorafshar AH, Angle N, Bryer-Ash M, Huang D, Farooq MM, Gelabert HA, Freischlag JA. Vascular endothelial growth factor inhibits mitogen-induced vascular smooth muscle cell proliferation. J Surg Res 2003;114:179-186.
32. Otrock ZK, Makarem JA Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: Review. Blood Cells Mol Dis 2007;38:258-268.
33. Ferrara N, Herber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-676.
34. Koch S, Yao C, Grieb G, Prével P, Noah EM, Steffens GCM. Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF. J Mater Sci Mater Med 2006;17:735-741.
35. Ito Y, Hasuda H, Terai H, Kitajima T. Culture of human umbilical vein endothelial cells on immobilized vascular endothelial growth factor. J Biomed Mater Res 2005;74A:659-665.
36. Laschke MW, Harder Y, Amon M, Martin I, Farhadi J, Ring A, Torio-Padron N, Schramm R, Rücker M, Junker D, Häufel JM, Carvalho C, Heberer M, Germann G, Vollmar B, Menger MD. Angiogenesis in tissue engineering: Breathing life into constructed tissue substrates. Tissue Eng 2006;12:2093-2104.
37. Levenberg S, Roukema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, Marini R, van Billterswijk CA, Mulligan RC, D'Amore PA, Langer R. Engineering vascularized skeletal muscle tissue. Nat Biotech 2005;23:879-884.
38. Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Büttner M, Rhiza HJ, Dehio C. A novel vascular endothelial growth factor encoded by Orf virus. VEGF-E, mediates angiogenesis via signaling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J 1999;18:363-374.
39. Aldenhoff YBJ, Knetsch MLW, Hanssen JHL, Lindhout T, Wielders S, Koole LH. Coils and tubes releasing heparin. Studies on a new vascular graft prototype. Biomaterials 2004;25:3125-3133.
40. Knetsch MLW, Aldenhoff YBJ, Schraven M, Koole LH. Human endothelial cell attachment and proliferation on a novel vascular graft prototype. J Biomed Mater Res 2004;71A:615-624.
41. Yamazaki Y, Morita T. Molecular and functional diversity of vascular endothelial growth factors. Mol Divers 2006;10:515-527.
42. Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: Review. Blood Cells Mol Dis 2007;38:258-268.
43. Inoue N, Kondo T, Kobayashi K, Aoki M, Numaguchi Y, Shibuya M, Murohara T. Therapeutic angiogenesis using novel vascular endothelial growth factor-E/human placental growth factor chimera genes. Arterioscler Thromb Vasc Biol 2007;27:99-105.
44. Shibuya M. Vascular endothelial growth factor (VEGF)-receptor 2: Its biological functions, major signaling pathway, and specific ligand VEGF-E. Endothelium 2006;13:63-69.
45. Heil M, Mitnacht-Kraus R, Issbrücker K, van den Heuvel J, Dehio C, Schaper W, Clauss M, Weich HA. An engineered heparin binding form of VEGF-E (hbVEGF-E). Angiogenesis 2003;6:201-211.
46. Knetsch MLW, Aldenhoff YBJ, Koole LH. The effect highdensity-lipoprotein on thrombus formation on and endothelial cell attachment to biomaterial surfaces. Biomaterials 2006;27:2813-2819.
47. Keuren JFW, Wielders SJH, Willems GM, Morra M, Cahalan L, Cahalan P, Lindhout T. Thrombogenicity of polysaccharide-coated surfaces. Biomaterials 2003;24:1917-1924.